Marina Kremyanskaya, MD, PhD, discusses the need for disease-modifying treatment approaches for patients with myeloproliferative neoplasms.
Marina Kremyanskaya, MD
Advertisement
Articles by Marina Kremyanskaya, MD
Marina Kremyanskaya, MD, PhD, discusses responses with CPI-0610 in patients with myelofibrosis.
Marina Kremyanskaya, MD, discusses the effect of CPI-0610 in patients with myelofibrosis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
Olverembatinib Plus Blinatumomab Yields High Early-Phase CR/CRi Rates in R/R Ph+ CML and B-ALL
4
Dr Falchi on Critical Unmet Needs and Important Next Steps in DLBCL
5